Home » Quibim Earns FDA Clearance for Prostate MRI Solution
Quibim Earns FDA Clearance for Prostate MRI Solution
Quibim has received FDA 510(k) clearance for qp-Prostate, an artificial intelligence-based magnetic resonance imaging (MRI) solution for analyzing the prostate.
The non-invasive solution assists in visualizing and quantifying the prostate to potentially help detect prostate cancer early on in patients.
The Valencia, Spain-based company said qp-Prostate is the only technology available that offers automatic regional organ segmentation that can help reduce interpretation time by identifying and segmenting each prostate region.
Upcoming Events
-
07May
-
14May
-
30May